{"id":"https://openalex.org/W2562015022","doi":"https://doi.org/10.1182/blood.v116.21.3155.3155","title":"Pathway Dependence on the Tyrosine Kinase TYK2 and Its Mediator STAT1 In T-Cell Acute Lymphoblastic Leukemia","display_name":"Pathway Dependence on the Tyrosine Kinase TYK2 and Its Mediator STAT1 In T-Cell Acute Lymphoblastic Leukemia","publication_year":2010,"publication_date":"2010-11-19","ids":{"openalex":"https://openalex.org/W2562015022","doi":"https://doi.org/10.1182/blood.v116.21.3155.3155","mag":"2562015022"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v116.21.3155.3155","doi":"https://doi.org/10.1182/blood.v116.21.3155.3155","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.3155.3155","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049972629","display_name":"Takaomi Sanda","orcid":"https://orcid.org/0000-0003-1621-4954","observed_orcids":["https://orcid.org/0000-0003-1621-4954"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Takaomi Sanda","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134831711","display_name":"Jeffrey W Tyner","orcid":"https://orcid.org/0000-0002-2133-0960","observed_orcids":["https://orcid.org/0000-0002-2133-0960"]},"institutions":[{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeffrey W Tyner","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA,","institution_ids":["https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043244661","display_name":"Alejandro Guti\u00e9rrez","orcid":"https://orcid.org/0000-0002-0249-9007","observed_orcids":["https://orcid.org/0000-0002-0249-9007"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandro Gutierrez","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital, Boston, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital, Boston, Boston, MA, USA,","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086889326","display_name":"Vu N. Ngo","orcid":"https://orcid.org/0000-0002-9501-6990","observed_orcids":["https://orcid.org/0000-0002-9501-6990"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Vu N Ngo","raw_affiliation_strings":["Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA,","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014678514","display_name":"Richard Moriggl","orcid":"https://orcid.org/0000-0003-0918-9463","observed_orcids":["https://orcid.org/0000-0003-0918-9463"]},"institutions":[{"id":"https://openalex.org/I4210151154","display_name":"Ludwig Boltzmann Institute for Cancer Research","ror":"https://ror.org/04abv6630","country_code":"AT","type":"facility","lineage":["https://openalex.org/I2799334681","https://openalex.org/I4210151154"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"Richard Moriggl","raw_affiliation_strings":["Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria,","institution_ids":["https://openalex.org/I4210151154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015594833","display_name":"Yebin Ahn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yebin Ahn","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006352059","display_name":"Jason Glover","orcid":"https://orcid.org/0009-0008-2323-9897","observed_orcids":["https://orcid.org/0009-0008-2323-9897"]},"institutions":[{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jason M Glover","raw_affiliation_strings":["Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA","institution_ids":["https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014427832","display_name":"Bill H. Chang","orcid":"https://orcid.org/0000-0003-3783-1820","observed_orcids":["https://orcid.org/0000-0003-3783-1820"]},"institutions":[{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bill H Chang","raw_affiliation_strings":["Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA","institution_ids":["https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108459816","display_name":"Stephanie G. Willis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephanie G Willis","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA,","institution_ids":["https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025942951","display_name":"Louis M. Staudt","orcid":"https://orcid.org/0000-0002-1735-2892","observed_orcids":["https://orcid.org/0000-0002-1735-2892"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louis M. Staudt","raw_affiliation_strings":["Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA,","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125591963","display_name":"Brian J. Druker","orcid":"https://orcid.org/0000-0001-8331-8206","observed_orcids":["https://orcid.org/0000-0001-8331-8206"]},"institutions":[{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian J Druker","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA,","institution_ids":["https://openalex.org/I4390039369"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085803011","display_name":"Alfred Thomas Look","orcid":"https://orcid.org/0000-0001-7851-8617","observed_orcids":["https://orcid.org/0000-0001-7851-8617","https://orcid.org/0000-0001-5410-6220"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Thomas Look","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital, Boston, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Children's Hospital, Boston, Boston, MA, USA,","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5006352059","https://openalex.org/A5014678514","https://openalex.org/A5015594833","https://openalex.org/A5049972629","https://openalex.org/A5086889326","https://openalex.org/A5108459816","https://openalex.org/A5134831711"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210117453","https://openalex.org/I4210140884","https://openalex.org/I4210151154","https://openalex.org/I4390039369"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.39533057,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"116","issue":"21","first_page":"3155","last_page":"3155"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.8407999873161316,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.8407999873161316,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.10100000351667404,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.01979999989271164,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":0.9580000042915344},{"id":"https://openalex.org/keywords/tyk2","display_name":"TYK2","score":0.9850000143051147},{"id":"https://openalex.org/keywords/stat1","display_name":"STAT1","score":0.9769999980926514},{"id":"https://openalex.org/keywords/jak-signaling","display_name":"JAK signaling","score":0.628000020980835},{"id":"https://openalex.org/keywords/interferon-signaling","display_name":"interferon signaling","score":0.6439999938011169},{"id":"https://openalex.org/keywords/ifnar","display_name":"IFNAR","score":0.8859999775886536},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5920000076293945},{"id":"https://openalex.org/keywords/lestaurtinib","display_name":"lestaurtinib","score":0.7739999890327454},{"id":"https://openalex.org/keywords/ag490","display_name":"AG490","score":0.921999990940094},{"id":"https://openalex.org/keywords/shrna-screen","display_name":"shRNA screen","score":0.5569999814033508},{"id":"https://openalex.org/keywords/cell-survival","display_name":"cell survival","score":0.4300000071525574},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.5649999976158142},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.5189999938011169},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.8769999742507935},{"id":"https://openalex.org/keywords/il-10-receptor","display_name":"IL-10 receptor","score":0.5070000290870667},{"id":"https://openalex.org/keywords/il-12-receptor","display_name":"IL-12 receptor","score":0.7770000100135803}],"concepts":[{"id":"https://openalex.org/C130523297","wikidata":"https://www.wikidata.org/wiki/Q14914487","display_name":"Tyrosine kinase 2","level":5,"score":0.8635728359222412},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.616893470287323},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.531489372253418},{"id":"https://openalex.org/C179464577","wikidata":"https://www.wikidata.org/wiki/Q1632589","display_name":"Jurkat cells","level":4,"score":0.46359342336654663},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.44382476806640625},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4415135681629181},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.43758222460746765},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.41044145822525024},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3583568036556244},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3537856936454773},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3293660283088684},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29122194647789},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23485156893730164},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2000522017478943},{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.11029276251792908},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.0703660249710083},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v116.21.3155.3155","doi":"https://doi.org/10.1182/blood.v116.21.3155.3155","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.3155.3155","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.75,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2047446990","https://openalex.org/W2102180682","https://openalex.org/W2980007401","https://openalex.org/W2980204146","https://openalex.org/W2616076633","https://openalex.org/W2588632822","https://openalex.org/W2981242526","https://openalex.org/W2341178063","https://openalex.org/W2138725796","https://openalex.org/W2603383201"],"abstract_inverted_index":{"Abstract":[0,1],"3155":[2],"The":[3],"often":[4],"aggressive":[5],"and":[6,22,43,190,205,221,223,229,275,292,301,328],"unpredictable":[7],"behavior":[8],"of":[9,29,70,84,91,103,123,143,157,165,227,235,248,255,261,330,340],"T-cell":[10,38,53],"lymphoblastic":[11,40],"malignancies":[12],"continues":[13],"to":[14,44,196,343],"pose":[15],"both":[16,298],"major":[17],"clinical":[18,357],"challenges":[19],"in":[20,37,62,101,111,161,185,212,271,287,311,324,359],"children":[21],"adults.":[23],"To":[24,207],"discover":[25],"oncogenic":[26],"pathways":[27,308],"downstream":[28,249],"critical":[30],"genetic":[31],"abnormalities":[32],"that":[33,78,89,108,135,154,178,191,225,253,265],"are":[34,79,194,309],"characteristically":[35],"deregulated":[36],"acute":[39],"leukemia":[41],"(T-ALL),":[42],"identify":[45,208],"novel":[46,353],"molecular":[47],"targets":[48],"for":[49,81,140,277,320,356],"anti-leukemic":[50],"agents":[51],"with":[52,150,303,361],"specificity,":[54],"we":[55,87,109,215],"carried":[56],"out":[57],"a":[58,67,93,318,352],"genome-wide":[59],"functional":[60],"screen":[61],"T-ALL":[63,85,105,144,187,236,262,289,331,341],"cell":[64,106,124,188,278,290,313],"lines":[65,107,125,291],"using":[66],"retroviral":[68],"library":[69],"inducible":[71],"short-hairpin":[72],"RNAs":[73],"(shRNAs).":[74],"Among":[75],"the":[76,82,121,141,155,179,233,259,272,321,326],"genes":[77],"required":[80,139,276],"growth":[83,122,142,234,260,327],"cells,":[86,237,263],"found":[88,177,224],"loss":[90,156,226,254],"TYK2,":[92],"JAK":[94,167,202],"family":[95],"tyrosine":[96],"kinase,":[97],"was":[98,284,295],"specifically":[99,138,231],"lethal":[100],"each":[102],"three":[104],"tested":[110],"this":[112,266,293,335,362],"screen.":[113],"By":[114],"contrast,":[115],"TYK2":[116,136,158,180,213,241,273,299,344],"knock-down":[117,149,164,246,300],"did":[118],"not":[119],"affect":[120],"from":[126],"diffuse":[127],"large":[128],"B-cell":[129],"lymphoma":[130],"or":[131,171],"multiple":[132,151],"myeloma,":[133],"indicating":[134,264],"is":[137,182,269],"cells.":[145,332],"We":[146,176],"confirmed":[147],"by":[148,297,346],"independent":[152],"shRNAs":[153],"induces":[159],"apoptosis":[160],"T-ALL,":[162],"whereas":[163],"other":[166],"proteins":[168,251],"(JAK1,":[169],"JAK2":[170],"JAK3)":[172],"had":[173],"no":[174],"effect.":[175],"protein":[181,283],"constitutively":[183,285],"phosphorylated":[184,286],"many":[186,288,312],"lines,":[189],"these":[192],"cells":[193,342],"sensitive":[195],"small":[197,347],"molecule":[198,348],"JAK/TYK2":[199,304],"inhibitors,":[200,349],"including":[201],"inhibitor-I,":[203],"AG-490":[204],"CEP-701.":[206],"upstream":[209],"receptors":[210],"involved":[211,270],"activation,":[214],"knocked":[216],"down":[217],"IFNAR,":[218],"IFNGR,":[219],"IL10R":[220],"IL12RB,":[222],"IFNAR1":[228],"IFNAR2":[230],"inhibit":[232],"as":[238,240],"strongly":[239],"knock-down.":[242],"In":[243,280],"addition,":[244],"targeted":[245],"analysis":[247],"STAT":[250],"revealed":[252],"STAT1":[256,282],"also":[257],"inhibits":[258],"transcription":[267],"factor":[268],"pathway":[274,323,336],"survival.":[279],"fact,":[281],"phosphorylation":[294],"inhibited":[296],"treatment":[302],"inhibitors.":[305],"Although":[306],"interferon-mediated":[307],"cytostatic":[310],"types,":[314],"our":[315],"results":[316],"indicate":[317],"requirement":[319],"IFNAR-TYK2-STAT1":[322],"promoting":[325],"survival":[329],"Dependence":[333],"on":[334],"confers":[337],"unique":[338],"sensitivity":[339],"inhibition":[345],"thus":[350],"providing":[351],"therapeutic":[354],"target":[355],"testing":[358],"patients":[360],"disease.":[363],"Disclosures:":[364],"Druker:":[365],"Molecular":[366],"MD:":[367],"Equity":[368],"Ownership.":[369]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-01-06T00:00:00"}